Philippines FDA approves EUA for India’s Covaxin, Johnson & Johnson’s Janssen

304

The Food and Drug Administration (FDA) has approved the application for emergency use application of India’s Bharat Biotech for its COVID-19 vaccine Covaxin and of Johnson and Johnson for its Janssen shots.

On Twitter, Indian Ambassador Shambhu Kumaran thanked Philippine officials for the approval of Bharat’s EUA application for Covaxin.

In a briefing chaired by President Rodrigo Duterte, vaccine czar Secretary Carlito Galvez announced that the FDA had issued the EUA for the Janssen vaccine.

Galvez thanked the FDA for the approval of the EUA.

On Twitter, Kumaran thanked the FDA, the Department of Health, and Foreign Affairs Secretary Teodoro Locsin Jr. He also congratulated Indian vaccine maker Bharat Biotech.

“Another decisive step in the long battle together against Covid-19!” Kumaran said.

Locsin also thanked India for its interest to apply for a EUA in the Philippines.

“Thank you, Philippines? You have nothing to thank us for. We thank you, we owe you the lives of our loved ones who would otherwise die because of pure idiots,” Locsin said in a tweet.

“Thank you, India” he added.

The FDA has found Bharat’s vaccine is 95% and 92% effective on the study population and among all races, respectively.

The Philippines has rolled out AstraZeneca and Sinovac COVID-19 vaccines for its mass immunization which started last March.

Source: By CONSUELO MARQUEZ, GMA News & India in Cambodia (Embassy of India, Phnom Penh)